Bladder cancer detection gets a boost with new imaging agent
NCT ID NCT05321316
First seen Mar 23, 2026 · Last updated May 15, 2026 · Updated 7 times
Summary
This study tests a new radioactive tracer called [68Ga]N188 for PET scans to find a protein called nectin-4 in people with urothelial carcinoma, a type of bladder cancer. The goal is to see if this tracer can better detect tumors, especially in patients with advanced or recurring cancer. About 20 adults aged 18-75 with measurable tumors will receive the tracer and undergo PET/CT imaging.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UROTHELIAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Cancer Hospital
RECRUITINGBeijing, Beijing Municipality, 100142, China
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.